U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 21 to 40 of 434

Tests names and labsConditionsGenes, analytes, and microbesMethods

qChip 400

Quantitative Genomic Medicine Laboratories, SL
Spain
184162
  • D Deletion/duplication analysis

Tempus xT

Tempus Labs, Inc.
United States
2646
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

RASopathy NGS Panel

UAB Medical Genomics Laboratory UAB Medicine
United States
818
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

Non-NF1 RASopathy NGS Panel

UAB Medical Genomics Laboratory UAB Medicine
United States
717
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

FoundationOne® Heme

Foundation Medicine, Inc.
United States
2405
  • D Deletion/duplication analysis
  • R RNA analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Onco microarray for MDS/AML

Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center
United States
270
  • D Deletion/duplication analysis
  • H Detection of homozygosity

CRANEO-FACIAL-CUTANEOUS SYNDROME

Clinical Genomics Unit Hospital Universitari Germans Trias i Pujol
Spain
15
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

NOONAN SYNDROME

Clinical Genomics Unit Hospital Universitari Germans Trias i Pujol
Spain
516
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

RASOPATHY-RELATED SYNDROME

Clinical Genomics Unit Hospital Universitari Germans Trias i Pujol
Spain
919
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

qChip 60k prenatal

Quantitative Genomic Medicine Laboratories, SL
Spain
184162
  • D Deletion/duplication analysis

Myeloid Next Generation Sequencing with Reflex Pathology Interp

Sentara Healthcare Laboratory Services
United States
369
  • T Targeted variant analysis

NEXT GEN SEQUENCING COMPREHENSIVE SOLID TUMOR PANEL

Alverno Laboratories
United States
127
  • T Targeted variant analysis

MayoComplete Lung Cancer Panel

Mayo Clinic Laboratories Mayo Clinic
United States
115
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Invitae Expanded Renal Disease Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
693388
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Multigene Myeloid Panel

UCSF Molecular Diagnostics Laboratory University of California, San Francisco
United States
152
  • X Mutation scanning of select exons

cfDNA KRAS 12, 13, 61, 146 Blood

Mayo Clinic Laboratories Mayo Clinic
United States
11
  • T Targeted variant analysis

KRAS Somatic Mutation Analysis, Peritoneal Fluid

Mayo Clinic Laboratories Mayo Clinic
United States
11
  • T Targeted variant analysis

KRAS Somatic Mutation Analysis, Tumor

Mayo Clinic Laboratories Mayo Clinic
United States
21
  • T Targeted variant analysis

OnkoSight Advanced Bladder Cancer Panel

BioReference Health
United States
139
  • C Sequence analysis of the entire coding region

OnkoSight Advanced Breast Cancer Panel

BioReference Health
United States
150
  • C Sequence analysis of the entire coding region

Results: 21 to 40 of 434

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.